Cogent Biosciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
COGT Nasdaq 2836 www.cogentbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cogent Biosciences, Inc.

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting - May 30th, 2026 6:00 am
Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST - May 28th, 2026 6:00 am
Assessing Cogent Biosciences (COGT) Valuation After A Strong Year And Recent Share Price Pullback - May 25th, 2026 6:18 pm
What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge - May 23rd, 2026 4:40 pm
Why a Biotech Fund Opened a New $6 Million Position in Vir Amid a 99% Stock Rally - May 23rd, 2026 4:33 pm
What to Know About This Fund’s New $22 Million Xenon Pharmaceuticals Buy Ahead of an FDA Filing - May 18th, 2026 11:44 am
Dianthus Therapeutics Is Up 320% in a Year. One Major Investor Just Reduced Its Stake but Still Seems Bullish - May 18th, 2026 11:33 am
Maze Therapeutics Stock Still Up 180% After March Tumble. One Fund Just Disclosed Selling $3 Million in Shares - May 17th, 2026 1:13 pm
Tyra Biosciences Stock Has Soared 280% in a Year. One Fund Just Disclosed Buying More Shares - May 17th, 2026 1:01 pm
This Biotech Has a June 30 FDA Catalyst. A Fund Just Cut Its Stake by $7 Million - May 17th, 2026 12:52 pm
This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million - May 17th, 2026 12:42 pm
Stanley Druckenmiller Just Exited Alphabet. TCI Fund Management Is Buying. - May 15th, 2026 3:59 pm
Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress - May 12th, 2026 7:30 am
Cogent Biosciences (COGT) Valuation After Wider Q1 Loss And Bezuclastinib Regulatory Progress - May 7th, 2026 12:26 am
Cogent Biosciences Reports Recent Business Highlights and First Quarter 2026 Financial Results - May 5th, 2026 6:00 am
Systemic Mastocytosis (SM) Treatment Market 2026-2035: Industry to More Than Double in Size, Led by Sanofi, AdvaCare Pharma, and Cogent Biosciences - May 1st, 2026 7:50 am
Cogent Biosciences Announces Oral Presentation of Positive Phase 3 PEAK Trial in Gastrointestinal Stromal Tumors (GIST) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting - Apr 21st, 2026 6:00 am
Cogent Biosciences Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 - Apr 17th, 2026 6:00 am
Does Bezuclastinib’s Real-Time FDA Review and NDA Filing Change The Bull Case For Cogent Biosciences (COGT)? - Apr 11th, 2026 9:10 pm
Southwest Airlines, Colliers International, and More Stocks See Action From Activist Investors - Apr 10th, 2026 3:28 pm